Package 67457-617-30

Brand: gemcitabine

Generic: gemcitabine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 67457-617-30
Digits Only 6745761730
Product NDC 67457-617
Product ID 67457-617_93d514c4-a877-475d-91e0-9cfb232d55ca
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (67457-617-30) / 26.3 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2017-12-18
Brand gemcitabine
Generic gemcitabine hydrochloride
Sample Package No

Linked Drug Pages (1)

Gemcitabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "93d514c4-a877-475d-91e0-9cfb232d55ca", "openfda": {"unii": ["U347PV74IL"], "rxcui": ["1720960", "1720975", "1720977"], "spl_set_id": ["06dd9d40-74fc-4409-93b1-a46be7126331"], "manufacturer_name": ["Mylan Institutional LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (67457-617-30)  / 26.3 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "67457-617-30", "marketing_start_date": "20171218"}], "brand_name": "Gemcitabine", "product_id": "67457-617_93d514c4-a877-475d-91e0-9cfb232d55ca", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "67457-617", "generic_name": "GEMCITABINE HYDROCHLORIDE", "labeler_name": "Mylan Institutional LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gemcitabine", "active_ingredients": [{"name": "GEMCITABINE HYDROCHLORIDE", "strength": "1 g/26.3mL"}], "application_number": "ANDA205242", "marketing_category": "ANDA", "marketing_start_date": "20171218", "listing_expiration_date": "20261231"}